Sensus Healthcare, Inc (SRTS) Dividend History

Company News

• Global Inulinase Market to Surpass USD 1,613.8 Million by 2034, Driven by 4.9% CAGR and Expanding Applications in Food, Beverages, and Dietary Supplements | Future Market Insights, Inc.

  The global inulinase market is expected to grow at a CAGR of 4.9% and reach a value of over $1.6 billion by 2034, driven by increasing demand for natural and health-focused products in the food, beverage, and dietary supplement industries.

  GlobeNewswire Inc.
• Recent Price Trend in Sensus Healthcare is Your Friend, Here's Why

  The article discusses the recent positive price trend in Sensus Healthcare (SRTS) and why it is a good investment opportunity. The stock has seen a steady increase in price over the past 12 weeks and 4 weeks, indicating a bullish trend. Additionally, the stock is trading at a high percentage of its 52-week range and has a favorable Zacks Rank and broker recommendation.

  Benzinga
• Sensus Healthcare, Inc. (SRTS) Stock Sinks As Market Gains: Here's Why

  In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $4.87, marking a -1.81% move from the previous day.

  Zacks Investment Research
• Sensus Healthcare, Inc. (SRTS) Stock Declines While Market Improves: Some Information for Investors

  Sensus Healthcare, Inc. (SRTS) closed at $5.22 in the latest trading session, marking a -1.51% move from the prior day.

  Zacks Investment Research
• Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade

  Sensus Healthcare, Inc. (SRTS) concluded the recent trading session at $5.48, signifying a -0.54% move from its prior day's close.

  Zacks Investment Research